Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 37(2): e22789, 2023 02.
Article in English | MEDLINE | ID: mdl-36692419

ABSTRACT

Crescent formation is the most important pathological finding that defines the prognosis of nephritis. Although neutrophils are known to play an important role in the progression of crescentic glomerulonephritis, such as anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis, the key chemoattractant for neutrophils in ANCA-associated glomerulonephritis has not been identified. Here, we demonstrate that a lipid chemoattractant, leukotriene B4 (LTB4 ), and its receptor BLT1 are primarily involved in disease pathogenesis in a mouse model of immune complex-mediated crescentic glomerulonephritis. Circulating neutrophils accumulated into glomeruli within 1 h after disease onset, which was accompanied by LTB4 accumulation in the kidney cortex, leading to kidney injury. LTB4 was produced by cross-linking of Fc gamma receptors on neutrophils. Mice deficient in BLT1 or LTB4 biosynthesis exhibited suppressed initial neutrophil infiltration and subsequent thrombotic glomerulonephritis and renal fibrosis. Depletion of neutrophils before, but not after, disease onset prevented proteinuria and kidney injury, indicating the essential role of neutrophils in the early phase of glomerulonephritis. Administration of a BLT1 antagonist before and after disease onset almost completely suppressed induction of glomerulonephritis. Finally, we found that the glomeruli from patients with ANCA-associated glomerulonephritis contained more BLT1-positive cells than glomeruli from patients with other etiologies. Taken together, the LTB4 -BLT1 axis is the key driver of neutrophilic glomerular inflammation, and will be a novel therapeutic target for the crescentic glomerulonephritis.


Subject(s)
Glomerulonephritis , Leukotriene B4 , Receptors, Leukotriene B4 , Animals , Mice , Antibodies, Antineutrophil Cytoplasmic , Antigen-Antibody Complex , Chemotactic Factors , Glomerulonephritis/pathology , Neutrophils/pathology , Receptors, Leukotriene B4/metabolism
2.
Biochem Biophys Res Commun ; 582: 49-56, 2021 12 10.
Article in English | MEDLINE | ID: mdl-34689105

ABSTRACT

The efficacy of n-3 polyunsaturated fatty acids (PUFAs) in improving outcomes in a renal ischemia-reperfusion injury (IRI) model has previously been reported. However, the underlying mechanisms remain poorly understood and few reports demonstrate how dietary n-3 PUFAs influence the composition of membrane phospholipids in the kidney. Additionally, it has not been elucidated whether perilla oil (PO), which is mainly composed of the n-3 alpha-linolenic acid, mitigates renal IRI. In this study, we investigated the effect of dietary n-3 PUFAs (PO), compared with an n-6 PUFA-rich soybean oil (SO) diet, on IRI-induced renal insufficiency in a rat model. Levels of membrane phospholipids containing n-3 PUFAs were higher in the kidney of PO-rich diet-fed rats than the SO-rich diet-fed rats. Levels of blood urea nitrogen and serum creatinine were significantly higher in the ischemia-reperfusion group than the sham group under both dietary conditions. However, no significant differences were observed in blood urea nitrogen, serum creatinine, or histological damage between PO-rich diet-fed rats and SO-rich diet-fed rats. In the kidney of PO-rich diet-fed rats, levels of arachidonic acid and arachidonic acid-derived pro-inflammatory lipid mediators were lower than SO-rich diet-fed rats. Eicosapentaenoic acid and eicosapentaenoic acid-derived lipid mediators were significantly higher in the kidney of PO-rich than SO-rich diet-fed rats. These results suggest that dietary n-3 PUFAs alter the fatty acid composition of membrane phospholipids and lipid mediators in the kidney; however, this does not attenuate renal insufficiency or histological damage in a renal IRI model.


Subject(s)
Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-6/metabolism , Renal Insufficiency/diet therapy , Reperfusion Injury/diet therapy , Soybean Oil/metabolism , Animals , Arachidonic Acid/metabolism , Blood Urea Nitrogen , Creatinine/blood , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-6/administration & dosage , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Lipid Metabolism/drug effects , Male , Phospholipids/metabolism , Plant Oils/chemistry , Rats , Rats, Sprague-Dawley , Renal Insufficiency/metabolism , Renal Insufficiency/pathology , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Soybean Oil/administration & dosage , Soybean Oil/chemistry , Treatment Failure , alpha-Linolenic Acid/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...